MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 901 to 920 of 1,960 approvalsPage 46 of 98

Xeljanz

Authorisation: Mar 22, 2017

Amgevita

Authorisation: Mar 21, 2017

Truxima

Authorisation: Feb 17, 2017

Truxima

Authorisation: Feb 17, 2017

Alecensa

Authorisation: Feb 16, 2017

Vihuma

Authorisation: Feb 13, 2017

Olumiant

Authorisation: Feb 13, 2017

Olumiant

Authorisation: Feb 13, 2017

Cystadrops

Authorisation: Jan 18, 2017

Cystadrops

Authorisation: Jan 18, 2017

Zinplava

Authorisation: Jan 18, 2017

Suliqua

Authorisation: Jan 11, 2017

Movymia

Authorisation: Jan 11, 2017

Vemlidy

Authorisation: Jan 9, 2017

Fiasp

Authorisation: Jan 9, 2017

Afstyla

Authorisation: Jan 4, 2017

Terrosa

Authorisation: Jan 4, 2017

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.